Summary of a National Institute of Mental Health workshop: developing animal models of anxiety disorders

Psychopharmacology
A ShekharL Winsky

Abstract

There exists a wide range of animal models and measures designed to assess anxiety or fearfulness. However, the relationship between these models and clinical anxiety symptoms and syndromes is unclear. The National Institute of Mental Health convened a workshop to discuss the relationship between existing behavioral models of anxiety and the clinical profile of anxiety disorders. A second goal of this workshop was to outline various approaches towards modeling components of anxiety disorders. To briefly describe epidemiological and behavioral manifestations of clinical anxiety syndromes and how they relate to commonly employed animal models of anxiety. To describe approaches and considerations for developing, improving, and adapting anxiety models to better understand the neurobiology of anxiety. Clinicians, psychiatrists and clinical and basic neuroscientists presented data exemplifying different approaches towards understanding anxiety and the role of animal models. Panel members outlined what they considered to be critical issues in developing and employing animal models of anxiety. This review summarizes the discussions and conclusions of the workshop including recommendations for improving upon existing models and strategi...Continue Reading

Citations

May 11, 2010·Psychopharmacology·Leanne M FraserAndré Ramos
Apr 3, 2009·Journal of Neural Transmission·Christa Hohoff
Jul 15, 2003·Current Psychiatry Reports·Joachim D K UysBrian H Harvey
Mar 24, 2004·Neuroscience and Biobehavioral Reviews·Christoph P Wiedenmayer
Dec 9, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Zul MeraliHymie Anisman
Feb 26, 2003·European Journal of Pharmacology·Mark J Millan, Mauricette Brocco
Feb 26, 2003·European Journal of Pharmacology·David L WalkerMichael Davis
Jan 22, 2002·Neuroscience and Biobehavioral Reviews·H ZangrossiF G Graeff
Mar 23, 2004·Behavioural Brain Research·Valeria CarolaFranco Mangia
Aug 21, 2003·Progress in Neurobiology·Mark J Millan
Oct 3, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Athina MarkouThomas Steckler
Jan 25, 2005·Nature Reviews. Drug Discovery·Chad J SwansonDarryle D Schoepp
Sep 3, 2005·Nature Reviews. Drug Discovery·John F Cryan, Andrew Holmes
Mar 2, 2006·Genes, Brain, and Behavior·V CarolaC Gross
Apr 6, 2006·Genes, Brain, and Behavior·P SaetreT F Bergström
Feb 6, 2010·Genes, Brain, and Behavior·Valeria Carola, Cornelius Gross
Jul 19, 2012·PloS One·Vladimira JakubcakovaMayumi Kimura
Sep 9, 2011·Future Neurology·Simone B SartoriNicolas Singewald
May 21, 2013·Journal of Pharmacological and Toxicological Methods·Vijender KumarDinesh Kumar
Aug 19, 2014·Neuroscience and Biobehavioral Reviews·Philip L JohnsonAnantha Shekhar
Sep 10, 2014·European Journal of Pharmacology·Deepali GuptaYeshwant Kurhe
Oct 2, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ankur JindalBaldev Kumar
Jul 15, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·D L WalkerM Davis
Jul 3, 2007·Frontiers in Neuroendocrinology·Joseph S Lonstein
Apr 14, 2016·Pharmacology Research & Perspectives·Abdelkader Ennaceur, Paul L Chazot
Oct 21, 2009·Depression and Anxiety·Steven P Hamilton
Nov 24, 2007·Fundamental & Clinical Pharmacology·Michel BourinMartine Hascöet
Mar 6, 2009·The Journal of Small Animal Practice·E YalcinH Batmaz
Dec 21, 2013·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Katharina Luise HupaMichael Stephan
Feb 1, 2005·Neurotoxicology and Teratology·Kathryn L HamiltonLisa M Schrott
Aug 30, 2003·Biological Psychiatry·Zul MeraliHymie Anisman
Nov 28, 2006·Neuroscience and Biobehavioral Reviews·B F P BroekmanF Boer
Apr 4, 2006·Journal of Pharmacological and Toxicological Methods·Nora Silvana ViglieccaMarisa Carola Peñalva
Mar 12, 2013·Neuroscience·M RazafshaF H Kobeissy
Jan 11, 2011·Behavioural Processes·Patricia A Kabitzke, Christoph P Wiedenmayer
Jun 15, 2016·Evidence-based Complementary and Alternative Medicine : ECAM·Jian LiJian-You Guo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.